Peregrine Ventures

Israel's first dedicated healthcare fund, investing in life science companies globally.

Venture Capital Active Or Yehuda, Israel Est. 2001
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
15
in our dataset
Rounds participated
22
Rounds led
12
Rounds' value
$481.2M
total disclosed, rounds participated
Stages
Pre-Seed, E Round, Seed, C Round, A Round, B Round, D Round

About

Peregrine Ventures is a leading Israeli venture capital fund established in 2001, dedicated to advancing medical innovation through strategic investments in life sciences. The firm invests across all stages of a company's lifecycle, from pre-seed through advanced growth stages, with a focus on healthcare, life sciences, digital health, medical devices, pharmaceuticals, and biotechnology. Peregrine Ventures provides comprehensive support beyond capital, including business strategy, team recruitment, and regulatory navigation. The firm manages over $300 million in assets and has a global investment strategy, with a particular interest in opportunities within Asia.

Portfolio · 15

Geomage Ltd.
Geomage Ltd. provides advanced seismic interpretation and processing software and services for the oil and gas industry.
Led ★ 1 round Latest: 2026-01
Restore Medical
A clinical-stage MedTech company developing transcatheter therapies for heart failure.
1 round $23.0M committed Latest: 2025-07
Focal Medical Technology
Revolutionizing Prostate Cancer Treatment with Precision.
Led ★ 2 rounds $830K committed Latest: 2025-05
EndoPulse
Developing the next generation of life-saving cardiac support.
Led ★ 1 round $1.4M committed Latest: 2025-05
Xerient
Developing novel therapeutics and diagnostic technologies for abdominal and gastrointestinal cancers, particularly pancreatic cancer.
Led ★ 1 round $1.0M committed Latest: 2025-02
Kanso Diagnostics
Kanso Diagnostics develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.
Led ★ 1 round Latest: 2024-08
4Oncology
In stealth mode, developing medical devices in the oncology sector.
1 round $10.0M committed Latest: 2024-05
Variantyx
A technology-driven molecular diagnostics company providing advanced genomic testing for genetic disorders, reproductive health, and precision oncology markets.
Led ★ 3 rounds $97.5M committed Latest: 2024-04
Bluewhite
AI-powered autonomy solutions for off-road applications, increasing productivity and safety.
2 rounds $49.0M committed Latest: 2024-01
BioProtect
Developer of biodegradable balloon implants designed to protect healthy tissue during radiation therapy for prostate cancer.
Led ★ 2 rounds $53.0M committed Latest: 2023-09
xFind
xFind is an AI-driven enterprise search platform that supercharges customer interactions with contextual knowledge.
Led ★ 1 round $3.0M committed Latest: 2023-07
Nectin Therapeutics
Nectin Therapeutics is a biotechnology company developing next-generation immune-oncology (IO) and antibody-drug conjugate (ADC) therapies for cancer patients.
Led ★ 2 rounds $25.0M committed Latest: 2023-05
Aleph Farms
A cellular agriculture company growing cultivated beef steaks directly from animal cells.
Led ★ 2 rounds $117.0M committed Latest: 2021-07
Surgical KIS
Surgical KIS is developing an innovative system, the SLEEK suture, to attach artificial valves to heart tissues more efficiently, quickly and precisely.
Led ★ 1 round $96.0M committed Latest: 2021-04
Kailight Photonics
Developer of optical modules for the global telecommunications industry.
Led ★ 1 round $4.5M committed Latest: 2006-01

Investment activity

17 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences47
Agriculture & Food Technologies4
Business Software4
Industrial Technologies1
Fintech & Insurtech1
Cyber Security1
Undisclosed1

Funds · 6

  • Peregrine III Annex Fund — $30M Jan 2021
  • Peregrine Growth Fund — $180.18M Jun 2020
  • Peregrine Fund IV — $115M Dec 2019
  • Peregrine Fund III — $75M Apr 2015
  • Peregrine Fund II — $27M Sep 2008
  • Peregrine Fund I — $15M Apr 2001

Q&A

What is Peregrine Ventures' primary investment focus?
Peregrine Ventures is an Israeli healthcare fund, primarily focusing on the Health Tech & Life Sciences sector, which accounts for 47 of its portfolio companies.
What was a recent notable exit for Peregrine Ventures?
In January 2026, Peregrine Ventures saw BioProtect acquired by Almeda Ventures for $200 million.
Can you name another recent exit for Peregrine Ventures?
In January 2025, Peregrine Ventures had an exit with EndoStream Medical, which was acquired by Kaneka Corporation for $100 million.
Which funds has Peregrine Ventures raised recently?
Peregrine Ventures raised the Peregrine III Annex Fund for $30 million in January 2021 and the Peregrine Growth Fund for $180.18 million in June 2020.
What is Peregrine Ventures' investment stage preference?
Peregrine Ventures invests across various stages including Pre-Seed, Seed, A Round, B Round, C Round, D Round, and E Round.
Who are the co-founders of Peregrine Ventures?
The co-founders and Managing General Partners of Peregrine Ventures are Boaz Lifschitz and Eyal Lifschitz.
What is Peregrine Ventures' most significant portfolio company by funding raised?
Insightec, a company developing MR-guided Focused Ultrasound Systems, has raised $592.9 million, making it one of Peregrine Ventures' most significantly funded portfolio companies.
How many investment rounds has Peregrine Ventures participated in within the last year?
In 2025, Peregrine Ventures participated in 19 investment rounds, and in 2024, they participated in 12 investment rounds.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)